“…Using data from a cohort of tested/diagnosed COVID-19 patients at MM, we performed what we believe is the first PheWAS looking at multiple COVID-19 outcomes stratified by race. A recently published PheWAS by Oetjens et al found 21 phenome-wide significant traits—including six kidney (e.g., end stage renal disease or stage 5 CKD [OR = 11.07, p = 1.96 × 10 −8 ]), six cardiovascular (e.g., congestive heart failure [OR = 3.8, p = 3.24 × 10 −5 ]), five respiratory (e.g., chronic airway obstruction [OR = 2.54, p = 3.71 × 10 −5 ]), and three metabolic (e.g., type 2 diabetes [OR = 1.80, p = 7.51 × 10 −5 ]) phenotypes—associated with COVID-19-related hospitalization, which is consistent with our results [ 14 ]. This technique allowed us to explore and identify potentially associated conditions across the medical phenome that are associated with susceptibility, hospitalization, ICU admission or mortality.…”